Which is better?! Saxenda or Wegovy? Y’all wanted to know and it just so happens a trial published in January of 2022 answered this very question!

The authors of this paper directly compared Saxenda 3mg daily and Wegovy 2.4mg once weekly. Who came out on top? Let’s take a look!

I have had several subscribers and followers asking about hair loss with the GLP-1 medications such as Ozempic and Saxenda – they have either been experiencing thinning of their hair OR they know someone who might be experiencing it. Let’s take a look and see what could be the cause.

If you have diabetes, you very likely have heard of metformin, or if you have been paying attention to the news in the last couple of years, you may have also heard of it being recalled. Now I am not here to talk about how bad metformin is; actually, quite the opposite! Instead, today we are talking about why some people might lose weight when taking metformin. Let’s go!

We have dealt with the top end, but what about the back end? Today we are talking about mitigating 2 other common side effects, constipation and diarrhea, that can occur with the GLP-1 receptor agonists such as Ozempic and Saxenda.

But before we get into how we manage those side effects, let’s talk about what constipation and diarrhea actually are.

Nausea is one of my least favorite bodily sensations to feel. Nonetheless, I am sure every single one of us has experienced nausea, and/or vomiting on many occasions over the course of our lives. The problem with nausea is it is like fatigue, it is nondescript and could have countless causes, everything from early pregnancy to a viral infection and everything in between.

Nausea is also a common side effect of the GLP-1 RAs medications used for diabetes and obesity.

This will be Part 1 of a multi-part series where I review how to manage the most common side effects that come with the GLP-1 RAs such as Ozempic, Wegovy and Saxenda.

Today we are starting with heartburn! Let’s go!

Nothing lasts forever. Especially in the world of drug development. A new medication from the drug company Eli Lilly called Tirzepatide will be seeking FDA approval for diabetes management in 2022, and I suspect it will be seeking approval for obesity management shortly thereafter. Trials have been completed, and tirzepatide has been shown to have some very remarkable results not only in managing blood sugars but also in weight-loss. Let’s take a look at the results and see if the King will still be standing!

I won’t apologize for my clickbait title. In a world where we are flooded with information, one needs to get creative with grabbing people’s attention. I also do have a problem with where Obesity medicine practice is headed and no one seems to be talking about it.

We have the data, we have the knowledge, and we have the agents that can provide additional support in managing an individual’s weight. So why the hell aren’t we doing a better job?